Know Cancer

or
forgot password
  • cancer clinical trials in la jolla, CA

  • A Companion Study for Patients Enrolled in Prior/Parent Ipilimumab Studies
    Scripps Cancer Center
    La Jolla, California 92037
    Melanoma
    Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
    University of California at San Diego
    La Jolla, California 92093
    Adenocarcinoma of the Colon, Stage II Colon Cancer
    Rituximab and/or Lenalidomide in Treating Patients With Follicular Non-Hodgkin's Lymphoma That is Not Refractory to Rituximab
    Rebecca and John Moores UCSD Cancer Center
    La Jolla, California 92093-0658
    Lymphoma
    Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients With Stage III or Stage IV Head and Neck Cancer
    Rebecca and John Moores UCSD Cancer Center
    La Jolla, California 92093-0658
    Head and Neck Cancer
    Adjunctive Efficacy Study Of The SoftScan® Optical Breast Imaging System
    University of California-San Diego - Rebecca and John Moores Cancer Center
    La Jolla, California 92093
    Breast Cancer
    Bevacizumab in Treating Patients With Angiosarcoma
    Rebecca and John Moores UCSD Cancer Center
    La Jolla, California 92093-0658
    Sarcoma
    Zoledronate or Observation in Maintaining Bone Mineral Density in Patients Who Are Undergoing Surgery to Remove Both Ovaries
    Rebecca and John Moores UCSD Cancer Center
    La Jolla, California 92093-0658
    Hereditary Breast/Ovarian Cancer (brca1, brca2), Osteoporosis, Ovarian Cancer
    Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
    Scripps Cancer Center

    Trial Locations
    Scripps Cancer Center
    University of California at San Diego
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer
    Bevacizumab, Sorafenib Tosylate, and Temsirolimus in Treating Patients With Metastatic Kidney Cancer
    University of California at San Diego
    La Jolla, California 92093
    Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer
    Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer
    Rebecca and John Moores UCSD Cancer Center
    La Jolla, California 92093-0658
    Breast Cancer
    Phenylbutyrate and Valganciclovir in Treating Patients With Relapsed or Refractory Epstein-Barr Virus-Positive Cancer
    Rebecca and John Moores UCSD Cancer Center
    La Jolla, California 92093-0658
    Gastric Cancer, Head and Neck Cancer, Lymphoma, Lymphoproliferative Disorder
    Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed, HIV-Associated Burkitt's Lymphoma
    Rebecca and John Moores UCSD Cancer Center
    La Jolla, California 92093-0658
    Lymphoma
    Azacitidine and Interferon Alfa in Treating Patients With Metastatic Melanoma
    Rebecca and John Moores UCSD Cancer Center
    La Jolla, California 92093-0658
    Melanoma (Skin)
    Sirolimus/Tacrolimus Versus Tacrolimus/Methotrexate for Preventing Graft-Versus-Host Disease (GVHD)
    UCSD Medical Center
    La Jolla, California 92093
    Leukemia, Myelocytic, Acute, Leukemia, Lymphocytic, Acute, Leukemia, Myeloid, Chronic, Myelodysplastic Syndromes
    AP5346 or Oxaliplatin in Treating Patients With Metastatic and/or Unresectable Recurrent Head and Neck Cancer
    Moores UCSD Cancer Center
    La Jolla, California 92093-0658
    Head and Neck Cancer
    Gefitinib and PEG-Interferon Alfa-2a in Treating Patients With Unresectable or Metastatic Skin Cancer
    Rebecca and John Moores UCSD Cancer Center
    La Jolla, California 92093-0658
    Non-Melanomatous Skin Cancer
    A Trial of Romidepsin for Progressive or Relapsed Peripheral T-cell Lymphoma
    University of California at San Diego - Moore Cancer institute
    La Jolla, California 92093
    Peripheral T-cell Lymphoma
    Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
    University of California at San Diego
    La Jolla, California 92093
    Male Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer
    A Phase 1/2a Study of ABT-263 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia
    Site Reference ID/Investigator# 5566
    La Jolla, California 92093-0820
    Chronic Lymphocytic Leukemia
    Study the Role of Positron Emission Mammography in Pre-surgical Planning for Breast Cancer
    Scripps Cancer Center
    La Jolla, California 92037
    Breast Cancer
    Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
    Rebecca and John Moores UCSD Cancer Center
    La Jolla, California 92093-0658
    Neurotoxicity Syndromes, Pain, Peripheral Neuropathy, Unspecified Adult Solid Tumor, Protocol Specific
    Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer
    University of California at San Diego
    La Jolla, California 92093
    Endometrial Cancer
    Comparison of Different Types of Surgery in Treating Patients With Stage IA Non-Small Cell Lung Cancer
    Rebecca and John Moores UCSD Cancer Center
    La Jolla, California 92093-0658
    Lung Cancer
    IGIV Study for Chronic ITP Patients Ages 3-70
    Scripps Cancer Center
    La Jolla, California 92037
    Idiopathic Thrombocytopenic Purpura
    Phase 2 Study of Carfilzomib in Relapsed and Refractory Multiple Myeloma
    Scripps Clinic
    La Jolla, California 92037
    Multiple Myeloma
    S-Adenosyl-L-Methionine Disulphate P-Toluene-Sulfonate in Preventing Liver Cancer in Patients With Chronic Hepatitis C Infection
    University of California at San Diego
    La Jolla, California 92093
    Adult Primary Liver Cancer, Hepatitis C Infection
    The Active After Cancer Trial (AACT)
    University of California at San Diego
    La Jolla, California 92093
    Breast Cancer, Colorectal Cancer
    CT-322 in Treating Patients With Recurrent Glioblastoma Multiforme and Combination Therapy With Irinotecan
    University of California, San Diego
    La Jolla, California 92037-1709
    Brain and Central Nervous System Tumors, Recurrent Glioblastoma Multiforme
    Memantine in Preventing Side Effects in Patients Undergoing Whole-Brain Radiation Therapy for Brain Metastases From Solid Tumors
    Rebecca and John Moores UCSD Cancer Center
    La Jolla, California 92093-0658
    Cognitive/Functional Effects, Metastatic Cancer, Neurotoxicity, Unspecified Adult Solid Tumor, Protocol Specific
    Efficacy and Safety of OncoGel™ Added to Chemotherapy and Radiation Before Surgery in Subjects With Esophageal Cancer
    University of California San Diego
    La Jolla, California 92093
    Esophageal Cancer, Adenocarcinoma of the Esophagus, Squamous Cell Carcinoma
    Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
    University of California at San Diego
    La Jolla, California 92093
    Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With Occult Primary, Recurrent Salivary Gland Cancer, Recurrent Squamous Cell Carcinoma of the Hypopharynx, Recurrent Squamous Cell Carcinoma of the Larynx, Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity, Recurrent Squamous Cell Carcinoma of the Nasopharynx, Recurrent Squamous Cell Carcinoma of the Oropharynx, Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Recurrent Verrucous Carcinoma of the Larynx, Recurrent Verrucous Carcinoma of the Oral Cavity, Salivary Gland Squamous Cell Carcinoma, Stage IV Salivary Gland Cancer, Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Larynx, Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IV Squamous Cell Carcinoma of the Nasopharynx, Stage IV Squamous Cell Carcinoma of the Oropharynx, Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IV Verrucous Carcinoma of the Larynx, Stage IV Verrucous Carcinoma of the Oral Cavity, Tongue Cancer, Untreated Metastatic Squamous Neck Cancer With Occult Primary
    Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
    University of California at San Diego
    La Jolla, California 92093
    Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    Combination Chemotherapy and Intensity-Modulated Radiation Therapy in Treating Patients Undergoing Surgery for Locally Advanced Rectal Cancer
    Rebecca and John Moores UCSD Cancer Center
    La Jolla, California 92093-0658
    Colorectal Cancer
    BETH Study: Treatment of HER2 Positive Breast Cancer With Chemotherapy Plus Trastuzumab vs Chemotherapy Plus Trastuzumab Plus Bevacizumab
    Scripps Cancer Center-San Diego

    Trial Locations
    Scripps Cancer Center-San Diego
    Hematology-La Jolla
    Sabina R. Wallach, MD., AMC
    Breast Cancer
    Efficacy of Electrical Stimulation for Dysphagia in Head & Neck Cancer Patients
    University of California, San Diego
    La Jolla, California 92037-1709
    Dysphagia
    AdV-tk Therapy With Surgery and Chemoradiation for Pancreas Cancer (PaTK01)
    Scripps Green Hospital/Scripps Cancer Center
    La Jolla, California 92037
    Pancreatic Adenocarcinoma, Pancreatic Cancer
    CyberKnife Radiosurgery for Organ-Confined Prostate Cancer: Homogenous Dose Distribution
    Scripps Cancer Center - CyberKnife of Southern California at Vista
    La Jolla, California 92037
    Prostate Cancer, Prostatic Cancer, Prostate Neoplasms, Prostatic Neoplasms, Cancer of the Prostate
    Study to Evaluate Exemestane With and Without SNDX-275 in Treatment of Postmenopausal Women With Advanced Breast Cancer
    Moores UCSD Cancer Center
    La Jolla, California 92093-0658
    Breast Cancer, Estrogen Receptor-Positive Breast Cancer, Breast Cancer, Estrogen Receptor-Positive, ER+ Breast Cancer
    Detecting Anal and Genital Human Papillomavirus Infection and Squamous Intraepithelial Lesions in HIV-Positive Patients Enrolled in AIDS Cancer Clinical Trials
    Rebecca and John Moores UCSD Cancer Center
    La Jolla, California 92093-0658
    Aids-related Malignancies, Lymphoma, Precancerous Condition, Sarcoma
    Pemetrexed and/or Sunitinib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
    University of California at San Diego
    La Jolla, California 92093
    Recurrent Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    Cardiac Safety Assessment Study of Picoplatin in Solid Tumors
    Moores UCSD Cancer Center
    La Jolla, California 92093-0658
    Solid Tumors
    To Evaluate Sipuleucel-T Manufactured With Different Concentrations of PA2024 Antigen
    UCSD Moores Cancer Center
    La Jolla, California 93093
    Prostate Cancer
    Diet and Physical Activity Change or Usual Care in Improving Survival in Patients With Previously Treated Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    Rebecca and John Moores UCSD Cancer Center
    La Jolla, California 92093-0658
    Cognitive/Functional Effects, Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer, Weight Changes
    A Long-Term Study of the Effects of Orally Administered SAR302503 in Patients With Myelofibrosis
    UCSD Moores Cancer Center
    La Jolla, California 93093
    Myelofibrosis
    Temsirolimus With or Without Megestrol and Tamoxifen in Treating Patients With Advanced, Persistent, or Recurrent Endometrial Cancer
    University of California at San Diego
    La Jolla, California 92093
    Recurrent Endometrial Carcinoma, Stage III Endometrial Carcinoma, Stage IV Endometrial Carcinoma
    Gemcitabine and Erlotinib Before and After Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
    Rebecca and John Moores UCSD Cancer Center
    La Jolla, California 92093-0658
    Pancreatic Cancer
    An Efficacy Study of MORAb-009 Amatuximab in Subjects With Pleural Mesothelioma
    University of California, San Diego
    La Jolla, California 92037-1709
    Malignant Pleural Mesothelioma
    Efficacy and Safety Study of OncoVEXGM-CSF Compared to GM-CSF in Melanoma
    University of California San Diego, Moores Cancer Center
    La Jolla, California 92093
    Melanoma
    Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer
    University of California at San Diego
    La Jolla, California 92093
    Male Breast Cancer, Recurrent Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    A Study of Nilotinib Versus Imatinib in GIST Patients
    University of California San Diego Dept of Moores Cancer Ctr (2)
    La Jolla, California 92093-0658
    Gastrointestinal Stromal Tumor (GIST)
    S0809: Capecitabine, Gemcitabine, and RT in Patients w/Cholangiocarcinoma of the Gallbladder or Bile Duct
    Rebecca and John Moores UCSD Cancer Center
    La Jolla, California 92093-0658
    Extrahepatic Bile Duct Cancer, Gallbladder Cancer
    Study of Subcutaneous Campath-1H in Patients With B-Cell CLL and Residual Disease After Chemotherapy
    University of California San Diego
    La Jolla, California 92093
    B-Cell Chronic Lymphocytic Leukemia
    Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer
    University of California at San Diego
    La Jolla, California 92093
    Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Recurrent Cervical Cancer, Stage IVB Cervical Cancer
    A Study Evaluating Efficacy of ABT-888 in Combination With Temozolomide in Metastatic Melanoma
    Site Reference ID/Investigator# 14609
    La Jolla, California 92093-0820
    Melanoma, Metastatic Melanoma, Skin Cancer